Benzene-fused heteroring derivatives and pharmaceutical...

Details Benzene-fused heteroring derivatives and pharmaceutical... Benzene-fused heteroring derivatives and pharmaceutical...

2006-03-07

2006-03-07

O'Sullivan, Peter (Department: 1621)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S213010, C514S217010, C514S221000, C540S552000, C540S569000, C540S593000, C540S594000, C540S595000

Reexamination Certificate

active

07008938

ABSTRACT:
A benzene-fused heteroring derivative of formula (I)wherein all symbols are the same as described in the specification, and a non-toxic salt thereof. The compound of formula (I) has an inhibitory activity against cysteine protease and therefore it is useful as an agent for the prophylaxis and/or treatment of immune diseases (autoimmune diseases, infectious diseases, etc.), inflammatory diseases (inflammatory bowel diseases, multiple cerebrosclerosis, arthritis, etc.), nerve degeneration diseases (Alzheimer's disease, muscular dystrophy, etc.), bone resorption diseases (osteoporosis, etc.), respiratory system diseases, diabetes, shock, etc.

REFERENCES:
patent: 6410556 (2002-06-01), Anderson et al.
patent: 6797720 (2004-09-01), Ohmoto et al.
patent: 06-192199 (1994-07-01), None

Affiliated with

Also associated with

Rating

Benzene-fused heteroring derivatives and pharmaceutical... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Benzene-fused heteroring derivatives and pharmaceutical..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzene-fused heteroring derivatives and pharmaceutical... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3546815